Published in Gut on January 01, 1992
Investigating stem cells in human colon by using methylation patterns. Proc Natl Acad Sci U S A (2001) 3.56
Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol Mol Biol Rev (1998) 3.09
Drosophila EGFR pathway coordinates stem cell proliferation and gut remodeling following infection. BMC Biol (2010) 1.98
A subpopulation of mouse esophageal basal cells has properties of stem cells with the capacity for self-renewal and lineage specification. J Clin Invest (2008) 1.69
Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance. J Oncol (2010) 1.63
A multiscale mathematical model of cancer, and its use in analyzing irradiation therapies. Theor Biol Med Model (2006) 1.46
Colorectal cancer incidence trends in the United States and United kingdom: evidence of right- to left-sided biological gradients with implications for screening. Cancer Res (2010) 1.42
Functions of p21 and p27 in the regenerating epithelial linings of the mouse small and large intestine. Cancer Biol Ther (2008) 1.41
Rectal epithelial cell proliferation patterns as predictors of adenomatous colorectal polyp recurrence. Gut (1993) 1.39
The stem cell population of the human colon crypt: analysis via methylation patterns. PLoS Comput Biol (2007) 1.38
Expression of Musashi-1 in human normal colon crypt cells: a possible stem cell marker of human colon epithelium. Dig Dis Sci (2003) 1.25
Distinct levels of Sox9 expression mark colon epithelial stem cells that form colonoids in culture. Am J Physiol Gastrointest Liver Physiol (2011) 1.23
Colorectal carcinogenesis--update and perspectives. World J Gastroenterol (2014) 1.19
Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas. Int J Colorectal Dis (2007) 1.18
Stimulation and inhibition of proliferation in the small intestinal crypts of the mouse after in vivo administration of growth factors. Gut (1995) 1.13
In situ detection of enterocytic apoptosis in normal colonic mucosa and in familial adenomatous polyposis. Gut (1995) 1.12
Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis. Cell Host Microbe (2013) 1.08
Hypermutable DNA chronicles the evolution of human colon cancer. Proc Natl Acad Sci U S A (2014) 1.02
Acute epithelial injury in the rat small intestine in vivo is associated with expanded expression of transforming growth factor alpha and beta. Gut (1996) 0.96
Cancerous stem cells: deviant stem cells with cancer-causing misbehavior. Stem Cell Res Ther (2010) 0.91
Human colonocytes in primary culture: a model to study epithelial growth, metabolism and differentiation. Int J Colorectal Dis (1994) 0.91
Investigation of Musashi-1 expressing cells in the murine model of dextran sodium sulfate-induced colitis. Dig Dis Sci (2006) 0.87
Study of the proliferation in human gastric mucosa after in vivo bromodeoxyuridine labelling. Gut (1993) 0.86
Effect of longterm placebo controlled calcium supplementation on sigmoidal cell proliferation in patients with sporadic adenomatous polyps. Gut (1996) 0.85
Gut commensal bacteria and regional Wnt gene expression in the proximal versus distal colon. Am J Pathol (2014) 0.85
Colonic epithelial cell proliferation in hereditary non-polyposis colorectal cancer. Gut (1998) 0.82
Prostaglandin E2 promotes intestinal repair through an adaptive cellular response of the epithelium. EMBO J (2016) 0.82
Modeling of stem cell dynamics in human colonic crypts in silico. J Gastroenterol (2014) 0.81
Dietary Lactobacillus rhamnosus GG Supplementation Improves the Mucosal Barrier Function in the Intestine of Weaned Piglets Challenged by Porcine Rotavirus. PLoS One (2016) 0.81
Cell proliferation, tumour growth and clinical outcome: gains and losses in intestinal cancer. Ann R Coll Surg Engl (1993) 0.81
Patterns of proliferative activity in the colonic crypt determine crypt stability and rates of somatic evolution. PLoS Comput Biol (2013) 0.80
Cell organisation in the colonic crypt: a theoretical comparison of the pedigree and niche concepts. PLoS One (2013) 0.79
The identification of high and low risk groups for colorectal cancer using rectal mucosal crypt cell production rate (CCPR). Br J Cancer (1993) 0.78
Immunoelectron microscopic localisation of transforming growth factor alpha in rat colon. Gut (1994) 0.77
Effects of calcium and vitamin D3 on transforming growth factors in rectal mucosa of sporadic colorectal adenoma patients: a randomized controlled trial. Mol Carcinog (2013) 0.77
Beta-7 integrin controls enterocyte migration in the small intestine. World J Gastroenterol (2015) 0.77
An agent-based model of anoikis in the colon crypt displays novel emergent behaviour consistent with biological observations. R Soc Open Sci (2017) 0.76
Colon Cancer Stem Cells: Bench-to-Bedside-New Therapeutical Approaches in Clinical Oncology for Disease Breakdown. Cancers (Basel) (2011) 0.76
The role of cell location and spatial gradients in the evolutionary dynamics of colon and intestinal crypts. Biol Direct (2016) 0.75
Intestinal genetic inactivation of caspase-8 diminishes migration of enterocytes. World J Gastroenterol (2015) 0.75
Cell and molecular mechanisms of pathogenesis and treatment of cancer. Postgrad Med J (1998) 0.75
Proliferation of human gastrointestinal epithelium. Gut (1992) 0.75
Effects of tumour necrosis factor-alpha on BrdU incorporation in cultured human enterocytes. Mediators Inflamm (1995) 0.75
The role of backward cell migration in two-hit mutants' production in the stem cell niche. PLoS One (2017) 0.75
A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry (1985) 2.72
Epithelial cell renewal in cultured rectal biopsies in ulcerative colitis. Gastroenterology (1973) 2.48
CELL PROLIFERATION KINETICS IN THE GASTROINTESTINAL TRACT OF MAN. II. CELL RENEWAL IN STOMACH, ILEUM, COLON, AND RECTUM. Gastroenterology (1963) 2.47
Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology (1987) 2.39
CELL PROLIFERATION KINETICS IN THE GASTROINTESTINAL TRACT OF MAN. I. CELL RENEWAL IN COLON AND RECTUM. J Clin Invest (1963) 2.27
Rate and pattern of epithelial cell proliferation in ulcerative colitis. Gut (1981) 2.08
CELL KINETICS IN THE JEJUNUM AND RECTUM OF MAN. Am J Dig Dis (1964) 1.80
Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer (1988) 1.77
The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry. Cytometry (1985) 1.71
Observations of cell renewal in human rectal mucosa in vivo with thymidine-H3. Gastroenterology (1961) 1.62
Cell renewal in the human rectum. In vitro autoradiographic study on active ulcerative colitis. Gastroenterology (1970) 1.49
Generation time of epithelial cells in the human colon. Nature (1962) 1.45
The influence of age on colonic epithelial cell proliferation. Cancer (1988) 1.38
Immunohistochemical study of epithelial cell proliferation in hyperplastic polyps, adenomas, and adenocarcinomas of the large bowel. Gastroenterology (1988) 1.32
Cell renewal in familial polyposis: comparison between polyps and adjacent healthy mucosa. Gastroenterology (1972) 1.30
Methods for the determination of epithelial cell kinetic parameters of human colonic epithelium isolated from surgical and biopsy specimens. Gastroenterology (1984) 1.30
Significance of the labeling index and labeling distribution as kinetic parameters in colorectal mucosa of cancer patients and DMH treated animals. Cancer (1982) 1.29
In vivo measurements in familial polyposis: kinetics and location of proliferating cells in colonic adenomas. Cancer Res (1982) 1.18
Cell population kinetics in the epithelium of the colon of the male rat. Virchows Arch B Cell Pathol (1978) 1.17
Use of bromodeoxyuridine for cell kinetic studies in intact animals. Cell Tissue Kinet (1986) 1.17
In vitro autoradiographic determination of cell kinetic parameters in adenocarcinomas and adjacent healthy mucosa of the human colon and rectum. Cancer Res (1976) 1.15
The labelled mitoses curve and the estimation of the parameters of the cell cycle. Cell Tissue Kinet (1972) 1.11
Study of the cell proliferation kinetics in ulcerative colitis, adenomatous polyps, and cancer. Cancer (1985) 1.08
CELL REPLICATION IN THE GASTROINTESTINAL TRACT OF MAN. Gastroenterology (1965) 1.06
Scoring mitotic activity in longitudinal sections of crypts of the small intestine. Cell Tissue Kinet (1988) 1.05
Strand breaks arising from the repair of the 5-bromodeoxyuridine-substituted template and methyl methanesulphonate-induced lesions can explain the formation of sister chromatid exchanges. Chromosoma (1985) 1.04
Tritiated thymidine incorporation into epithelial cells of normal-appearing colorectal mucosa of cancer patients. J Natl Cancer Inst (1977) 1.00
The spatial organization of the hierarchical proliferative cells of the crypts of the small intestine into clusters of 'synchronized' cells. Cell Tissue Kinet (1982) 1.00
Double labelling with bromodeoxyuridine and [3H]-thymidine of proliferative cells in small intestinal epithelium in steady state and after irradiation. Cell Tissue Kinet (1988) 0.99
Cell proliferation at different sites along the length of the rat colon. Virchows Arch B Cell Pathol Incl Mol Pathol (1979) 0.95
Cell cycle parameters in human colon: comparison between primary and recurrent adenocarcinomas, benign polyps and adjacent unaffected mucosa. Cancer (1977) 0.92
Colorectal cancer. Cell kinetics. Recent Results Cancer Res (1982) 0.91
Circadian variation in migration velocity in small intestinal epithelium. Cell Tissue Kinet (1986) 0.90
In vivo determinations of labelling index of metastatic colorectal carcinoma and normal colonic mucosa using intravenous infusions of bromodeoxyuridine. J Surg Oncol (1988) 0.89
Cell proliferation in gastrointestinal disease. Natl Cancer Inst Monogr (1969) 0.82
[Distribution of the proliferative compartment in the colorectal mucosa in normal subjects, in preneoplastic cases and in cancer (author's transl)]. Acta Gastroenterol Belg (1978) 0.81
Cell proliferation in human tumour xenografts: measurement using antibody labelling against bromodeoxyuridine and Ki-67. Cell Prolif (1991) 0.81
Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res (2000) 5.74
An SNP map of human chromosome 22. Nature (2000) 2.99
Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis (2012) 2.78
Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer. Dis Esophagus (2006) 2.60
Resolution of peanut allergy: case-control study. BMJ (1998) 2.11
Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancer. Clin Radiol (2012) 2.08
Cell production rates in human tissues and tumours and their significance. Part II: clinical data. Eur J Surg Oncol (2000) 1.95
A new measure of conservatism. Br J Soc Clin Psychol (1968) 1.87
Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality. Intern Med J (2001) 1.83
Determination of continuing medical education needs of clinicians from a literature search study, Part I. The study. Bull Med Libr Assoc (1977) 1.83
Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results. Int J Radiat Oncol Biol Phys (1995) 1.77
Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project. Am J Psychiatry (2000) 1.77
Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF. Hum Reprod (2011) 1.72
The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry. Cytometry (1985) 1.71
The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br J Cancer (1997) 1.63
Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. Int J Radiat Biol (1999) 1.61
GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. Br J Cancer (2003) 1.57
Proliferation characteristics of human colorectal carcinomas measured in vivo. Br J Surg (1991) 1.55
Undesirable cytokeratin immunoreactivity of native nonepithelial cells in sentinel lymph nodes from patients with breast carcinoma. Arch Pathol Lab Med (2000) 1.52
Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinoma. Br J Surg (2009) 1.52
The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy. Radiother Oncol (1992) 1.51
Efficacy of chromium supplementation in athletes: emphasis on anabolism. Int J Sport Nutr (1992) 1.49
Genetic predisposition in breast cancer. Lancet (1994) 1.47
Nitric oxide binding to nitrophorin 4 induces complete distal pocket burial. Nat Struct Biol (2000) 1.46
Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. Br J Cancer (2005) 1.45
Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab (1999) 1.42
Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. Br J Cancer (1993) 1.42
Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription. J Clin Pharm Ther (2007) 1.42
A prospective analysis of c-myc oncoprotein levels as a prognostic marker in malignant melanoma. J Plast Reconstr Aesthet Surg (2007) 1.41
Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer. Radiother Oncol (2000) 1.39
Flow cytometric analysis of p53 oncoprotein expression in cutaneous melanoma. Br J Surg (1997) 1.38
Identification of viable embryos in IVF by non-invasive measurement of amino acid turnover. Hum Reprod (2004) 1.34
The role of nonrandomized trials in the evaluation of oncology drugs. Clin Pharmacol Ther (2015) 1.32
X-linked retinoschisis: clinical phenotype and RS1 genotype in 86 UK patients. J Med Genet (2005) 1.30
Cranial hemihypertrophy and neurodevelopmental prognosis. J Med Genet (1990) 1.29
A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study. Br J Cancer (2009) 1.27
The temporal and spatial changes in cell proliferation within the irradiated crypts of the murine small intestine. Int J Radiat Biol (1990) 1.26
Bone geometry and density in the skeleton of pre-pubertal gymnasts and school children. Bone (2005) 1.25
Affective modulation of the startle response in depression: influence of the severity of depression, anhedonia, and anxiety. J Affect Disord (2004) 1.24
The crypt cycle in mouse small intestinal epithelium. J Cell Sci (1994) 1.24
Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells. Nucleic Acids Res (2001) 1.24
Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck. Br J Cancer (1992) 1.24
Radiosensitivity testing of primary cervical carcinoma: evaluation of intra- and inter-tumour heterogeneity. Radiother Oncol (1990) 1.23
Problems of correlations between explanatory variables in multiple regression analyses in the dental literature. Br Dent J (2005) 1.22
Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: a test for predisposition? Br J Cancer (1998) 1.21
Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int J Cancer (1991) 1.21
The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer (1988) 1.19
Prognostic significance of 5T4 oncofetal antigen expression in colorectal carcinoma. Br J Cancer (1994) 1.19
The number of clonogenic cells in crypts in three regions of murine large intestine. Int J Radiat Biol (1997) 1.19
A randomized, controlled trial of vitamin D supplementation upon musculoskeletal health in postmenarchal females. J Clin Endocrinol Metab (2010) 1.18
The clonogen content of murine intestinal crypts: dependence on radiation dose used in its determination. Radiat Res (1992) 1.15
Parental attitudes and information needs in an adolescent HPV vaccination programme. Br J Cancer (2008) 1.15
The relationship between the supply of cardiac catheterization laboratories, cardiologists and the use of invasive cardiac procedures in northern New England. J Health Serv Res Policy (1997) 1.15
Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. Radiother Oncol (1995) 1.14
Cell migration in the small and large bowel shows a strong circadian rhythm. Epithelial Cell Biol (1994) 1.14
Altered stem cell regeneration in irradiated intestinal crypts of senescent mice. J Cell Sci (1998) 1.14
Spermatogonial apoptosis has three morphologically recognizable phases and shows no circadian rhythm during normal spermatogenesis in the rat. Cell Prolif (1992) 1.14
Chromosomal radiosensitivity as a marker of predisposition to common cancers? Br J Cancer (2001) 1.13
Results of speech perception and speech production training for three prelingually deaf patients using a multiple-electrode cochlear implant. Br J Audiol (1991) 1.12
Antimetabolites produced by microorganisms. X. L-2-amino-4-(2-aminoethoxy)-trans-3-butenoic acid. J Antibiot (Tokyo) (1974) 1.11
Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection. Br J Cancer (1991) 1.11
Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys (1998) 1.11
The potential impact of periodontal disease on general health: a consensus view. Curr Med Res Opin (2008) 1.09
Ro 22-5417, a new clavam antibiotic from Streptomyces clavuligerus. I. Discovery and biological activity. J Antibiot (Tokyo) (1983) 1.08
Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breast. J Pathol (1992) 1.07
Retracted Specific antigen exclusion and non-specific facilitation of antigen entry across the gut in rats allergic to food proteins. Clin Exp Immunol (1981) 1.06
Advances in cell kinetics. BMJ (1991) 1.05
Relationship between childhood behavioral disturbance and later schizophrenia in the New York High-Risk Project. Am J Psychiatry (1999) 1.05
The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. Radiother Oncol (1999) 1.05
Scoring mitotic activity in longitudinal sections of crypts of the small intestine. Cell Tissue Kinet (1988) 1.05
Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clin Infect Dis (2001) 1.05
A review of factors affecting blood biochemistry in the pig. Br Vet J (1972) 1.04
Thermal tolerance trade-offs associated with the right arm of chromosome 3 and marked by the hsr-omega gene in Drosophila melanogaster. Heredity (Edinb) (2003) 1.04
Normal tissue radiobiology: from the laboratory to the clinic. Int J Radiat Oncol Biol Phys (2001) 1.04
Prognostic significance of body mass indices for patients undergoing esophagectomy for cancer. Dis Esophagus (2007) 1.04
High tumor angiogenesis is associated with poorer survival in carcinoma of the cervix treated with radiotherapy. Clin Cancer Res (1998) 1.03
Provocation of allergic response by supplementary feeds of cows' milk. Arch Dis Child (1982) 1.03
Chromosomal radiosensitivity in G2-phase lymphocytes as an indicator of cancer predisposition. Radiat Res (1996) 1.01
Abnormal radiosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: chromosome aberrations after low dose-rate irradiation. Int J Radiat Biol (1995) 1.01
Specific suppression of rat IgE responses with milk from immunized females and with feeds of serum antibody. Immunology (1983) 1.01
Bioreductive fluorescent markers for hypoxic cells: a study of 2-nitroimidazoles with 1-substituents containing fluorescent, bridgehead-nitrogen, bicyclic systems. J Med Chem (1992) 1.00
Social and psychological factors in the distribution of STD in male clinic attenders. I Demographic and social factors. Br J Vener Dis (1983) 0.99
Biological and hormonal markers of chlamydia, human papillomavirus, and bacterial vaginosis among adolescents attending genitourinary medicine clinics. Sex Transm Infect (2005) 0.99
Sexual orientation and the 2nd to 4th finger length ratio: evidence for organising effects of sex hormones or developmental instability? Psychoneuroendocrinology (2003) 0.99
Proliferation indices of invasive breast carcinomas after in vivo 5-bromo-2'-deoxyuridine labelling: a flow cytometric study of 75 tumours. Br J Surg (1992) 0.99
The New York High-Risk Project. Prevalence and comorbidity of axis I disorders in offspring of schizophrenic parents at 25-year follow-up. Arch Gen Psychiatry (1997) 0.99
A randomized controlled trial on cross-infection control in maxillofacial trauma surgery: a comparison of intermaxillary fixation techniques. Int J Oral Maxillofac Surg (2008) 0.98
A detailed immunohistochemical analysis of cerebellar hemangioblastoma: an undifferentiated mesenchymal tumor. Mod Pathol (1989) 0.98
Extended-spectrum beta-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand. J Hosp Infect (2008) 0.98
Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia--a five-year retrospective review. Eur J Clin Microbiol Infect Dis (2009) 0.97
Prognostic significance of failure to cross esophageal tumors by endoluminal ultrasound. Dis Esophagus (2008) 0.96
5T4 oncofetal antigen in gastric carcinoma and its clinical significance. Eur J Gastroenterol Hepatol (1998) 0.96
Comparison of the BOD POD with the four-compartment model in adult females. Med Sci Sports Exerc (2001) 0.96
Heritability of chromosomal radiosensitivity in breast cancer patients: a pilot study with the lymphocyte micronucleus assay. Int J Radiat Biol (2000) 0.96